ABSTRACT Various parameters of erythrocyte membrane sodium transport were measured in patients with untreated essential hypertension, in the normotensive offspring of parents with hypertension, and in patients whose hypertension had been controlled by medication. Net sodium efflux, measured by an isotopic tracer technique, was 2.12 + 0.17 mM Na+/l of red blood cells (RBCs)/hr in patients with untreated essential hypertension, compared with 1.55 + 0.12 mM Na/l of RBCs/hr in a group of normotensive controls (p < .025). Partitioning sodium efflux into ouabain-sensitive and ouabain-insensitive components revealed a significant elevation of both components of membrane sodium transport in the patients with untreated essential hypertension. Ouabain-sensitive sodium efflux was 1.38 0.09 mM Na/l RBCs/hr in the patients, compared with 1.04 + 0.07 mM Na/l RBCs/hr in the controls. Ouabain-insensitive sodium efflux was also increased from 0.51 0.05 mM Na/l RBCs/ hr in the controls to 0.74 ± 0.09 mM Na/l RBCs/hr in those with untreated hypertension. Despite these changes in sodium efflux, Na,K-ATPase activity in the erythrocyte membrane, measured at maximum velocity (V5), was normal, suggesting that the observed abnormalities in membrane sodium transport in patients with untreated essential hypertension resulted from a change in pump control mechanisms rather than a change in enzyme activity. With the techniques used in this study we were unable to identify changes in erythrocyte membrane transport in the normotensive offspring of hypertensive parents. Membrane sodium transport was also examined in hypertensive patients whose blood pressure had been controlled by medication. In this group it was found that erythrocyte sodium transport did not differ from that in our control group 
cell membrane. We have used these three techniques to assess membrane sodium transport in four groups of subjects. Group A consisted of patients with untreated essential hypertension. Group B consisted of patients with essential hypertension whose blood pressure had been controlled by medication. Group C consisted of normotensive subjects with a family history of hypertension. Group D consisted of control subjects with no family history of hypertension.
Methods
Selection of study subjects. Nine patients with newly diagnosed untreated essential hypertension were selected for detailed studies of erythrocyte sodium transport. They ranged in age from 20 to 54 years. Diastolic blood pressure varied from 95 to 115 mm Hg (mean 106) and systolic blood pressure from 140 to 190 mm Hg (mean 156). To determine the cause of the hypertension, the following studies were performed in all patients: serum electrolytes, hemogram, urinalysis, urine culture and sensitivity, serum thyroxine, 24 hr creatinine clearance, peripheral vein renin, and hypertensive intravenous pyelogram. On the basis of these studies all patients were judged to have essential hypertension. One patient had polycystic kidney dis-COLE ease and one patient had a small stone in the left renal pelvis; both these patients had normal renal function. Peripheral vein renin related to the 24 hr urinary sodium excretion was not elevated in any of the patients in the study. After informed consent was obtained, the patients were asked to come to the laboratory, where blood was drawn for "cold" flux studies and erythrocytes membranes were prepared for ATPase assay. The patients returned 1 
Results
The result of measuring red cell sodium in the four groups of patients is shown in figure 1 A patients. The difference was not statistically significant.
Discussion
Abnormalities in erythrocyte membrane sodium transport in patients with hypertension have been recognized for many years.'3 "" Present interest in this topic was sparked by a series of papers by Garay et al. 2' 12, 11-16 in which he reported a decreased net Na/K flux ratio in patients with essential hypertension but not in patients with renovascular hypertension. Similar abnormalities were observed in some of the normotensive offspring of hypertensive patients. 12' 15 Subsequently, decreased Na K cotransport out of the erythrocyte in patients and some of the relatives of patients with essential hypertension but an accompanying increase in net sodium extrusion was reported.2 '4 It was suggested that such studies could be used to differentiate between essential and secondary hypertension and could be used to detect normotensive offspring of hypertensive parents who had a potential risk of developing hypertension. 16 These findings have not been confirmed by all investigators, with some groups reporting an increase in Na K cotransport in patients with essential hypertension and others reporting no change. 4 6.8 For studies such as these to be technically feasible, it is necessary to load the erythrocytes with high concentrations of sodium by preincubation with PCMBS, a powerful sulfydryl inhibitor that poisons the normal transport pathways of the cell. It can be argued that the observed changes in membrane transport in the erythrocytes of patients with hypertension may partly result from a differing susceptibility to sulfydryl inhibition.
A more physiologic method of studying erythrocyte sodium transport is to use radioactive tracers, which allow sodium flux studies to be performed at approximately the same concentration of intracellular sodium as exists in vivo. With isotopic flux techniques sodium transport can be compartmentalized into ouabain-sensitive and ouabain plus ethacrynic acid-sensitive components. Hoffman'9 has labeled the former component 20 of sodium transport pump I, and the latter pump II. The efflux of sodium that remains in the presence of maximal inhibitory concentrations of ouabain and ethacrynic acid is thought to represent passive outward leakage.20 With these techniques we have shown an increase in total sodium efflux in patients with essential hypertension when compared with normal controls. The addition of inhibitors of active transport to our flux medium revealed a significant increase in both ouabain-sensitive and ouabain-insensitive components of sodium efflux. The most marked increase in sodium transport was in the effiux that remained after the addition of both ouabain and ethacrynic acid to the flux medium. This latter observation would tend to confirm the work of Mahoney et al.,4 who found a significant increase in erythrocyte Na22 uptake in patients with essential hypertension. Fitzgibbon et al.,I with a slightly different technique, showed increased total sodium efflux in patients with essential hypertension.
Other investigators have measured a furosemidesensitive ouabain-insensitive sodium-lithium countertransport system in sodium loaded erythrocytes and found this to be increased in patients with hypertension.7 This finding may be related to our observation of increased ouabain-insensitive Na22 efflux, although it is difficult to draw any firm conclusion on this point, since we did not measure sodium-lithium countertransport per se.
The enzyme system responsible for ouabain-sensitive sodium efflux from the erythrocyte is a ouabainsensitive Na,K-activated ATPase. We measured the maximal activity of this enzyme system in fragmented erythrocyte membranes from patients with essential hypertension and found, in agreement with the studies of Swarts et al.," that ATPase activity was normal. This suggests that the increase in ouabain-sensitive sodium efflux in essential hypertension involves a change in the control mechanism for this component of the sodium pump rather than a change in the underlying enzyme activity. A third component of our study involved measuring net sodium and potassium fluxes after sodium loading of the erythrocytes in the presence of a sulfydryl inhibitor. Despite efforts to keep the loading conditions as uniform as possible, a wide variation in cell sodium at the end of the loading period was noted ( figure 2 and  table 3 ). Because of the strong correlation between the rate of sodium efflux and the intracellular sodium, this variation may have obscured differences in net sodium efflux between the four groups of study subjects. However, we were unable to confirm the findings of Garay et al. '2 In addition to studying membrane sodium transport in patients with untreated essential hypertension, we performed similar studies in treated patients and in normal individuals with a family history of hypertension. In the latter group of individuals we were unable to demonstrate any significant changes in erythrocyte membrane transport. In most of the studies that have been done on this group, the observed changes in membrane transport were less pronounced than in patients with essential hypertension. It may have been that the techniques that we were using were not sufficiently specific to detect an abnormality in this group.
Very few studies of erythrocyte sodium transport have been done in patients with treated essential hypertension, despite the obvious clinical interest in studying this group of patients. In our study of eight hypertensive patients whose blood pressure had been controlled with medication for at least 5 years, we found that the abnormalities in membrane sodium transport, which were noted in patients with untreated essential hypertension, were not present. This suggests that treatment of hypertension reverses the underlying changes in membrane transport. All vasodilators and/or sympathetic blocking agents. Additional studies will be necessary to determine how quickly normalization of erythrocyte membrane sodium transport occurs and whether all antihypertensive agents have the same effect.
The interactions of the various components of sodium efflux in the cell membrane are complex and as yet poorly understood. In this study we made no effort to directly examine Na K cotransport or sodium lithium counter transport. The effect of treatment of hypertension on these two components of sodium effiux remains to be studied, as does the interaction between these components of sodium efflux and ouabain-sensitive Na-K exchange.
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